Therapeutic drug monitoring in patients with inflammatory bowel disease

doi:10.3748/wjg.v20.i13.3475

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 13

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7790)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

613

WORD

275

HTML

4563

Figures (1-4)

176

Sum=5627

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1093

Download

1070

Sum=2163

Apr 7, 2014 (publication date) through May 22, 2024

Times Cited of This Article

Times Cited (44)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Apr 7, 2014; 20(13): 3475-3484
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3475

Full Size Figure Download Figure

Figure 4 Approaches to patients on infliximab in the setting of lose of response. ATI: Anti-infliximab antibody; IFX: Infliximab; TNF: Tumor necrosis factor.

Citation: Yarur AJ, Abreu MT, Deshpande AR, Kerman DH, Sussman DA. Therapeutic drug monitoring in patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(13): 3475-3484
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3475.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3475